Pharma research company accelerates validation processes by 75% with Res_Q

A pharmaceutical research company faced significant validation challenges managing 8-10 software releases annually across multiple SaaS applications using inefficient "paper-paperless" processes involving printing, scanning, and manual file handling across dispersed locations. It implemented Res_Q, a cloud-based validation platform built on AWS infrastructure, to automate and unify validation workflows. The implementation eliminated validation debt, reduced total validation time by 30-40%, accelerated overall validation by 75%, and freed labor equivalent to one full-time employee. As the VP of QA and Digital Systems put it: "What used to take us weeks or months now takes us days or weeks... The system enforces controls, eliminating the long chain of corrections we needed to manage using paper-based processes."

Sware is a GxP validation platform whose entire commercial focus is life sciences — used specifically to validate AI/ML systems' explainable, traceable decisions for regulatory scrutiny.

This sits in the Scale & Govern stage of the AI use-case lifecycle: Named examples from the tools pharma teams use to monitor, govern and keep validating an AI system once it is already live in production.